Clinical features of invasive pulmonary aspergillosis vs. colonization in COPD patients distributed by gold stage
详细信息    查看全文
文摘
| Figures/TablesFigures/Tables | ReferencesReferences

Summary

Objective

To explore clinical features of invasive pulmonary aspergillosis (IPA) vs. colonization among hospitalized COPD patients.

Methods

Records of COPD patients with two respiratory cultures yielding Aspergillus were retrospectively reviewed. Cases categorized as proven/probable IPA or colonization was analyzed.

Results

118 patients were identified: 70 (59.3 % ) colonized, 48 (40.7 % ) with IPA (42 probable, 6 proven). Higher percentage of IPA patients (vs. colonized) presented GOLD III?+?IV (77.1 % vs. 57.1 % , p?=?0.025). IPA patients presented higher Charlson index (3.5?¡À?2.5 vs. 2.6?¡À?2.2, p?=?0.027), higher rate of ICU admission (27.1 % vs. 4.3 % , p?=?0.001) and worse prognosis (McCabe rapidly fatal category: 31.3 % vs. 7.1 % , p?=?0.001). GOLD-I IPA patients presented risk factors other than COPD. Before hospitalization, 66.7 % IPA and 28.6 % colonized patients were taking steroids (p?<?0.001). Antifungals were administered to 83.3 % IPA and 21.4 % colonized patients (p?<?0.001). Mortality was higher among IPA vs. colonized patients, both in global (58.3 % vs. 10.0 % , p?<?0.001), GOLD-I (75.0 % vs. 10.0 % , p?=?0.041), GOLD-II (42.9 % vs. 5.0 % , p?=?0.042) and GOLD-III patients (54.2 % vs. 0.0 % , p?<?0.001), but not in GOLD-IV patients (69.2 % vs. 31.3 % , p?=?0.066).

Conclusions

IPA should be suspected not only in GOLD-III and GOLD-IV COPD patients, with higher mortality in IPA vs. colonized patients for GOLD-II and -III COPD patients.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700